6o6w: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Solution structure of human myeloid-derived growth factor== | ==Solution structure of human myeloid-derived growth factor== | ||
<StructureSection load='6o6w' size='340' side='right'caption='[[6o6w | <StructureSection load='6o6w' size='340' side='right'caption='[[6o6w]]' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[6o6w]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[6o6w]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O6W OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6O6W FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6o6w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o6w OCA], [https://pdbe.org/6o6w PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6o6w RCSB], [https://www.ebi.ac.uk/pdbsum/6o6w PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6o6w ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/MYDGF_HUMAN MYDGF_HUMAN] Bone marrow-derived monocyte and paracrine-acting protein that promotes cardiac myocyte survival and adaptive angiogenesis for cardiac protection and/or repair after myocardial infarction (MI). Stimulates endothelial cell proliferation through a MAPK1/3-, STAT3- and CCND1-mediated signaling pathway. Inhibits cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling pathway (By similarity). Involved in endothelial cell proliferation and angiogenesis (PubMed:25581518).[UniProtKB:Q9CPT4]<ref>PMID:25581518</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 22: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Bortnov | [[Category: Bortnov V]] | ||
[[Category: Lee | [[Category: Lee W]] | ||
[[Category: Markley | [[Category: Markley JL]] | ||
[[Category: Mosher | [[Category: Mosher DF]] | ||
[[Category: Tonelli | [[Category: Tonelli M]] | ||
Latest revision as of 05:31, 21 November 2024
Solution structure of human myeloid-derived growth factor
| ||||||||||||